Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 24, 2023
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
[ Fri, Feb 24th 2023
] - WOPRAI
Ami Fadia Maintained (AVDL) at Strong Buy and Held Target at $11 on, Feb 24th, 2023
Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $11 on, Feb 24th, 2023.
Ami has made no other calls on AVDL in the last 4 months.
There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ami
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $13 on, Tuesday, February 7th, 2023
- Chris Howerton of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Wednesday, November 30th, 2022
